Cetera Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $7.32M | Buy |
83,977
+32,564
| +63% | +$2.78M | 0.06% | 337 |
|
|
2023
Q4 | $4.24M | Sell |
51,413
-4,693
| -8% | -$358K | 0.06% | 317 |
|
|
2023
Q3 | $4.4M | Sell |
56,106
-11,093
| -17% | -$929K | 0.07% | 278 |
|
|
2023
Q2 | $5.92M | Buy |
67,199
+603
| +0.9% | +$51.9K | 0.09% | 214 |
|
|
2023
Q1 | $5.37M | Buy |
66,596
+7,231
| +12% | +$589K | 0.09% | 235 |
|
|
2022
Q4 | $4.61M | Buy |
59,365
+17,524
| +42% | +$1.42M | 0.08% | 255 |
|
|
2022
Q3 | $3.38M | Buy |
41,841
+2,352
| +6% | +$211K | 0.09% | 238 |
|
|
2022
Q2 | $3.54M | Sell |
39,489
-17,306
| -30% | -$1.75M | 0.08% | 259 |
|
|
2022
Q1 | $6.3M | Buy |
56,795
+24,504
| +76% | +$2.59M | 0.13% | 164 |
|
|
2021
Q4 | $3.34M | Sell |
32,291
-2,382
| -7% | -$276K | 0.07% | 290 |
|
|
2021
Q3 | $4.35M | Buy |
34,673
+3,289
| +10% | +$426K | 0.08% | 244 |
|
|
2021
Q2 | $3.9M | Buy |
31,384
+1,782
| +6% | +$224K | 0.09% | 226 |
|
|
2021
Q1 | $3.5M | Buy |
29,602
+5,855
| +25% | +$686K | 0.1% | 210 |
|
|
2020
Q4 | $2.78M | Buy |
23,747
+6,484
| +38% | +$714K | 0.09% | 214 |
|
|
2020
Q3 | $1.79M | Buy |
17,263
+3,910
| +29% | +$393K | 0.07% | 264 |
|
|
2020
Q2 | $1.23M | Buy |
13,353
+3,260
| +32% | +$313K | 0.05% | 316 |
|
|
2020
Q1 | $910K | Buy |
10,093
+176
| +2% | +$18.7K | 0.05% | 339 |
|
|
2019
Q4 | $1.12M | Buy |
9,917
+319
| +3% | +$35K | 0.05% | 349 |
|
|
2019
Q3 | $1.04M | Sell |
9,598
-2,722
| -22% | -$284K | 0.05% | 345 |
|
|
2019
Q2 | $1.2M | Buy |
12,320
+3,409
| +38% | +$311K | 0.05% | 330 |
|
|
2019
Q1 | $811K | Sell |
8,911
-241
| -3% | -$21.6K | 0.04% | 375 |
|
|
2018
Q4 | $833K | Sell |
9,152
-39
| -0.4% | -$3.64K | 0.05% | 349 |
|
|
2018
Q3 | $905K | Buy |
9,191
+2,608
| +40% | +$241K | 0.04% | 385 |
|
|
2018
Q2 | $563K | Sell |
6,583
-43
| -0.6% | -$3.59K | 0.03% | 474 |
|
|
2018
Q1 | $534K | Buy |
6,626
+1,090
| +20% | +$89.9K | 0.03% | 456 |
|
|
2017
Q4 | $446K | Buy |
5,536
+895
| +19% | +$71.7K | 0.03% | 472 |
|
|
2017
Q3 | $363K | Sell |
4,641
-25
| -0.5% | -$2.08K | 0.02% | 557 |
|
|
2017
Q2 | $414K | Sell |
4,666
-498
| -10% | -$42K | 0.03% | 520 |
|
|
2017
Q1 | $415K | Buy |
5,164
+178
| +4% | +$13.9K | 0.03% | 489 |
|
|
2016
Q4 | $355K | Sell |
4,986
-1,235
| -20% | -$97K | 0.03% | 492 |
|
|
2016
Q3 | $538K | Sell |
6,221
-23,049
| -79% | -$2.01M | 0.04% | 395 |
|
|
2016
Q2 | $2.54M | Sell |
29,270
-2,057
| -7% | -$166K | 0.2% | 125 |
|
|
2016
Q1 | $2.36M | Sell |
31,327
-1,936
| -6% | -$146K | 0.2% | 126 |
|
|
2015
Q4 | $2.56M | Sell |
33,263
-1,370
| -4% | -$103K | 0.22% | 118 |
|
|
2015
Q3 | $2.31M | Sell |
34,633
-1,713
| -5% | -$126K | 0.22% | 116 |
|
|
2015
Q2 | $2.69M | Sell |
36,346
-642
| -2% | -$49.1K | 0.23% | 111 |
|
|
2015
Q1 | $2.89M | Buy |
36,988
+12,572
| +51% | +$953K | 0.27% | 91 |
|
|
2014
Q4 | $1.75M | Sell |
24,416
-1,580
| -6% | -$110K | 0.17% | 149 |
|
|
2014
Q3 | $1.6M | Buy |
25,996
+2,441
| +10% | +$155K | 0.12% | 151 |
|
|
2014
Q2 | $1.51M | Buy |
23,555
+17,867
| +314% | +$1.09M | 0.17% | 158 |
|
|
2014
Q1 | $348K | Sell |
5,688
-2,291
| -29% | -$133K | 0.05% | 372 |
|
|
2013
Q4 | $458K | Buy |
+7,979
| New | +$452K | 0.07% | 298 |
|
Other funds holding MDT
Cetera Advisors's MDT Position: Q1 2024 in Review
Cetera Advisors increased its Medtronic (MDT) stake by 63% in Q1 2024, buying an estimated $2.78M and bringing the position to 83,977 shares worth $7.32M. The position accounts for 0.06% of the portfolio, ranked #337.
Cetera Advisors first reported a position in MDT in Q4 2013 and has held it in 42 quarters since. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.
- Cetera Advisors held 83,977 shares of Medtronic worth $7.32M as of Q1 2024.
- Cetera Advisors bought 32,564 Medtronic shares in Q1 2024, an estimated $2.78M.
- Medtronic made up 0.06% of Cetera Advisors's portfolio in Q1 2024, its #337 holding.
- Cetera Advisors first reported a position in Medtronic in Q4 2013 and has held it in 42 quarters since.
- 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.
Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.